QNRX
Quoin Pharmaceuticals, Ltd.
1W: +21.3%
1M: +8.8%
3M: -30.8%
YTD: -32.5%
1Y: -8.2%
3Y: -95.4%
5Y: -100.0%
$9.27
+1.27 (+15.88%)
After Hours: $8.54 (-0.72, -7.82%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$5.5M
52W Range5.01-41.8
Volume4,112,792
Avg Volume28,788
Beta1.82
Dividend—
Analyst Ratings
Company Info
CEOMichael Myers
Employees3
SectorHealthcare
IndustryBiotechnology
IPO Date2016-08-01
Websitequoinpharma.com
42127 Pleasant Forest Court
Ashburn, VA 20148-7349
US
Ashburn, VA 20148-7349
US
703 980 4182
About Quoin Pharmaceuticals, Ltd.
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
Latest News
Quoin Pharmaceuticals Provides Clinical and Regulatory Update from Constructive Type C Meeting with U.S. FDA for QRX003 in Netherton Syndrome
Quoin Pharmaceuticals to Announce Corporate Update and Fourth Quarter and Full-Year 2025 Financial Results on Thursday, March 26, 2026
Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome
Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome
Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Cooper Joseph Patric | A-Award | 8,141 | $7.37 | 2026-02-04 |
| Culverwell Anthony J | A-Award | 21,709 | $7.37 | 2026-02-04 |
| Myers Michael | A-Award | 318,750 | $7.37 | 2026-02-04 |
| Carter Denise P. | A-Award | 318,750 | $7.37 | 2026-02-04 |
| LANGER DENNIS | A-Award | 21,709 | $7.37 | 2026-02-04 |